Oral contraceptives and mortality from venous thromboembolism [1]

Lancet

Volumn 348, Issue 9034, 1996, Pages 1095-1097

  Farmer, R ^a   Lewis, M ^a   Van Lunsen, R H W ^a   Cohen, J ^a   Vandenbroucke, J P ^a   Bloemenkamp, K W M ^a   Helmerhorst, F M ^a   Rosendaal, F R ^a   Thomas, S H L ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; GESTODENE; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

CAUSE OF DEATH; DRUG SAFETY; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; LETTER; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK; VEIN THROMBOSIS; ADOLESCENT; ADULT; CHEMICALLY INDUCED DISORDER; EPIDEMIOLOGY; NETHERLANDS; NOTE; THROMBOEMBOLISM; MALE;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; NETHERLANDS; THROMBOEMBOLISM; MALE;

EID: 0029812165     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)24042-5     Document Type: Letter

References (2)

1. JP Vandenbroucke KWM Bloemenkamp FM Helmerhorst FR Rosendaal Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands Lancet 348 1996 401 402
2. SHL Thomas Mortality from venous thromboembolism and myocardial infarction in young adults in England and Wales Lancet 348 1996 402